• Sample Page

Targeting the ubiquitin–proteasome system for cancer therapy

GSK256066

Purpose To compare the clinical manifestations between individuals with ocular myasthenia

July 13, 2017 by Katherine Lewis Leave a Comment

Purpose To compare the clinical manifestations between individuals with ocular myasthenia gravis and the ones with generalized myasthenia gravis (MG). two organizations was borderline significant (= 0.058). The most frequent symptoms were ptosis and diplopia and both combined groups offered pain blurred vision and tearing. Systemic autoimmune disease was even more prominent in the generalized … [Read more…]

Posted in: EGFR Tagged: GSK256066, Rabbit Polyclonal to PITPNB.

Copyright © 2026 Targeting the ubiquitin–proteasome system for cancer therapy.

Omega Child WordPress Theme by